Comprehensive Guide to the Interventional Oncology Market in 2025

According to FutureWise analysis the Interventional Oncology Market in 2025 is US$ 2.85 billion, and is expected to reach US$ 5.03 billion by 2033 at a CAGR of 7.36%. The rising global cancer rates and the increasing demand for less invasive treatments are driving the growth of interventional oncology.This area is becoming crucial for cancer treatment, providing targeted therapies that usually lead to quicker recovery periods and reduced side effects compared to conventional methods, backed by improvements in imaging-guided therapies.

Interventional oncology is a specialized branch of interventional radiology focused on the diagnosis, treatment, and management of cancers using minimally invasive, image-guided procedures. This evolving field combines advanced imaging technologies with precise therapeutic techniques, allowing healthcare professionals to target tumors effectively while minimizing damage to surrounding healthy tissues. As a result, interventional oncology has greatly enhanced cancer care by providing less invasive alternatives to traditional surgical methods, which leads to shorter recovery times, reduced complications, and improved quality of life for patients.

Common interventional oncology procedures include various ablation techniques, such as radiofrequency, microwave, and cryoablation, which aim to destroy tumors through the application of heat or cold. Embolization therapies, like transarterial chemoembolization and radioembolization, are also utilized to cut off a tumor's blood supply or to administer localized chemotherapy or radiation. Image-guided biopsies are performed to obtain precise cancer diagnoses. These procedures can be applied to a variety of cancers affecting organs such as the liver, lung, kidney, and bone, particularly for patients who may not be suitable candidates for traditional surgery due to advanced disease or other health concerns.

The discipline leverages cutting-edge imaging techniques—including computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound—to ensure high accuracy during interventions. This technological proficiency allows interventional oncologists to target tumors as small as a few millimeters while preserving healthy tissue. Interventional oncology is often integrated into multidisciplinary cancer treatment plans, complementing surgical procedures, chemotherapy, and radiation therapy. It also plays a valuable role in palliative care, particularly in alleviating symptoms like pain or obstruction in patients with advanced cancer.

Recent advancements in the field, such as robotic guidance, artificial intelligence, and the development of new embolic agents, are further improving the precision and effectiveness of interventional oncology. As this specialty continues to evolve, it is driven by ongoing technological innovations and an expanding body of research that highlights its significance in personalized cancer treatment. By providing targeted, less invasive options, interventional oncology empowers patients with greater choices in their healthcare. Ultimately, it plays a vital role in the changing landscape of oncology, effectively connecting diagnostic processes with therapeutic interventions.

FutureWise Market Research has published a report that provides an insightful analysis of Interventional Oncology Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=2336&type=requestsample

Interventional Oncology Market Segmentation:

By Product

• Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Embolic Agents
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
• Support Devices
  • Microcatheters
  • Guidewires

By Procedure

• Thermal Tumour Ablation
• Non-thermal Tumour Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Interventional Oncology Market:

• Medtronic
• Boston Scientific
• BTG Plc.
• Terumo
• Merit Medical
• Sirtex
• Ethicon
• Cook Medical
• Teleflex
• HealthTronics
• MedWaves Medical
• IceCure Medical
• Interface Biomaterial BV
• Mermaid Medicals
• ABK Biomedical
• Guerbet
• Endo Shape
• Instylla
• Shape Memory Medical
• Monteris Medical
• Trisalus Lifesciences

Recent developments by key players in Interventional Oncology Market:

Sirtex

In July 2025, the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma (HCC). This approval makes it the only radioembolization therapy in the United States that is authorized for both metastatic colorectal cancer (mCRC) and HCC.

Boston Scientific

• Acquisition of Intera Oncology (Nov 2024): Integrated the Intera 3000 Hepatic Artery Infusion Pump and floxuridine, enhancing treatment options for liver metastases.
• Boston Scientific offers a variety of interventional oncology and embolization products, including Y-90 microspheres, coils, beads, and cryoablation systems. Their goal is to provide targeted treatments that improve the lives of patients facing cancer and other serious diseases.

Medtronic

• AI-powered ablation technologies: Advancing leadership in ablation through innovative imaging and AI tools, with a significant emphasis on the Asia-Pacific region.
• Pulsed-field systems achievement: Its interventional oncology ablation segment achieved US $1 billion in FY25, reflecting approximately 30% year-over-year growth.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=2336&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Interventional Oncology Market By Product, By Procedure, By Cancer Type and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

Website: www.futurewiseresearch.com